Slingshot members are tracking this event:
CHMP Recommends Approval of Bristol-Myers Squibb's (BMY) Opdivo as Single Agent for Squamous Cell Cancer of the Head and Neck After Platinum-Based Chemotherapy
Slingshot Insights Explained
Mar 24, 2017
Don’t see a project related to the catalyst you care about?
Related Keywords Chmp, Opdivo, Squamous Cell Cancer, Head And Neck Cancer, Platinum-based Chemotherapy, European Medicines Agency